VBI Vaccines Inc/BC Depreciation
VBI Vaccines Inc/BC reported Depreciation of $1.99 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-04-16
- VBI Vaccines Inc/BC depreciation for fiscal 2023 was $1.99M, a 0.95% decline from fiscal 2022.
- VBI Vaccines Inc/BC depreciation for fiscal 2022 was $2.01M, a 13.63% increase from fiscal 2021.
- VBI Vaccines Inc/BC depreciation for fiscal 2021 was $1.77M, a 111235.01% increase from fiscal 2020.
- VBI Vaccines Inc/BC depreciation for fiscal 2020 was $1.59K, a 99.86% decline from fiscal 2019.
| Period end | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|
| 2023-12-31 | $1.99M 10-K · filed 2024-04-16 | |
| 2022-12-31 | $2.01M 10-K · filed 2024-04-16 | |
| 2021-12-31 | $1.77M 10-K · filed 2023-03-13 | $1.77K 10-K · filed 2022-03-07 |
| 2020-12-31 | $1.59K 10-K · filed 2022-03-07 | $1.59M 10-K · filed 2021-03-02 |
| 2019-12-31 | $1.14M 10-K · filed 2021-03-02 | |
| 2018-12-31 | $481.00K 10-K · filed 2020-03-05 | |
| 2017-12-31 | $667.00K 10-K · filed 2019-02-25 | |
| 2016-12-31 | $540.00K 10-K · filed 2018-02-26 | |
| 2015-12-31 | $428.00K 10-K · filed 2018-02-26 |